Booster Shots a Likely Reality for COVID-19-Vaccinated Americans
And, CDC has scheduled a new emergency hearing on the safety of J&J vaccine for April 23
Antipsychotic Use Up for Teens, Young Adults From 2006 to 2010
No increase in use for those aged 1 to 12 years; males more likely to use antipsychotics than females
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers
HPV vaccine, screening offer opportunity to prevent 12,000 cervical CAs, 40,000 HPV-linked CAs/year
Risk for Myocarditis Low After BNT162b2 Booster in Israel
Risk estimates (cases per 100,000) 6.44 and 5.21 for males aged 16 to 19 and 20 to 24 years, respectively, compared with 1.42 overall
One-Cycle BE500P Seems Safe for High-Risk Early Testicular Cancer
Malignant recurrence rate was 1.3 percent at two years for one-cycle BE500P in high-risk early-stage disease
Oral Azithromycin Equivalent to Six Weeks Doxycycline for Meibomian Gland Dysfunction
Equivalence seen in total meibomian gland dysfunction score and Ocular Surface Disease Index score; no more adverse effects seen in azithromycin group
AAP: Guidelines Updated for Lice Infestation Among Children
American Academy of Pediatrics also gives advice on best medicines to treat infestation
Multimethod Approach Improves ID of Med Nonadherence
Use of provider report, medication possession ratio improved ID of nonadherence in youth with CKD
Enobosarm Has Antitumor Activity in ER-Positive, HER2-Negative Advanced Breast Cancer
At 24 weeks, 32 and 29 percent of patients in the 9-mg and 18-mg groups had clinical benefit
